Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

TRX4 evaluated in new phase I study for psoriasis

Aug. 5, 2004

Positive European opinion for use of Enbrel in psoriasis

Aug. 3, 2004

Preliminary 30-month data show benefit of Raptiva in psoriasis

Aug. 2, 2004

Neurokinin 1 receptor antagonist effective against postoperative fibrous adhesions

July 30, 2004

PediaMed and Allergan enter pediatrics copromotion agreement for Tazorac

July 30, 2004

FDA approval for Metvix

July 30, 2004

Fully human anti-ICAM antibody effective in murine psoriasis model

July 23, 2004

Enrollment completed for Fibrostat phase IIb study

July 22, 2004

Promising vitamin D analogue for the treatment of psoriasis

July 21, 2004

FDA Advisory Committee recommends against approval of oral tazarotene

July 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...